StemGen, Inc (the “Company”) was incorporated in Delaware in 1992, and in 1996 received all remaining assets of Infotechnology, Inc. (“Infotech”), a Delaware company, following the completion of Infotech’s Chapter 11 Bankruptcy reorganization, in accordance with an Assignment and Assumption Agreement, dated October 11, 1996, and effective as of June 21, 1996. As a result of a series of transactions during the 1980’s, Infotech, then principally engaged in the information and communications business, acquired equity interests in Comtex News Network, Inc. (“Comtex”) and Analex Corporation (“Analex”), formerly known as Hadron, Inc. Our business was the maintenance of our equity interest in and note receivable from Comtex and equity interest in Analex.

Company profile
Ticker
SGNI
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Microsoft • Oracle • NortonLifeLock • BlackBerry • Activision Blizzard • Vmware • Adobe • Ceridian HCM Holding • McAfee • Electronic Arts ...
Former names
AMASYS CORP
SEC CIK
Corporate docs
IRS number
541812385
Press releases
D3eSports Announces Supporting Partnership With United States Esports Federation (USEF)
5 Aug 22
D3eSports Announces TCG World For New eSports Series
28 Jun 22
D3eSports Proudly Announces First Hotel Resort Simulator Destination in Partnership with Newly Launched Team Jamaica
26 May 22
D3eSports Announces Team Jamaica for New eSports Series
20 May 22
Calendar
3 Aug 22
12 Aug 22
30 Jun 23
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 21 | Jun 20 | Jun 19 | Jun 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial report summary
?Management Discussion
- For the fiscal year ended June 30, 2021, the Company had a net loss of $433,143 and negative cash flow from operations of $141,196. As of June 30, 2021, the Company has negative working capital of $1,734,314.
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Removed:
generated
Current reports
8-K
Stemgen Announces Impressive Excutive Management Team
8 Feb 21
8-K
Changes in Registrant's Certifying Accountant
19 Mar 20
8-K
Changes in Registrant's Certifying Accountant
3 Mar 20
8-K
Entry into a Material Definitive Agreement
21 May 19
8-K/A
Entry into a Material Definitive Agreement
15 Feb 19
8-K/A
Entry into a Material Definitive Agreement
1 Feb 19
8-K
Entry into a Material Definitive Agreement
19 Dec 18
8-K
Departure of Directors or Certain Officers
28 Feb 18
8-K
Changes in Registrant's Certifying Accountant
19 Oct 17
8-K
Unregistered Sales of Equity Securities
12 Mar 15
Other
EFFECT
Notice of effectiveness
31 Jul 20
CORRESP
Correspondence with SEC
28 Jul 20
CORRESP
Correspondence with SEC
28 Jul 20
CORRESP
Correspondence with SEC
13 Jul 20
UPLOAD
Letter from SEC
5 Jul 20
CORRESP
Correspondence with SEC
22 Jun 20
UPLOAD
Letter from SEC
27 May 20
CORRESP
Correspondence with SEC
14 May 20
UPLOAD
Letter from SEC
20 Jan 10
CORRESP
Correspondence with SEC
10 Jan 10